Louise leads ESG integration within equities at Aviva Investors across investment desks. She provides ESG sector coverage for the TMT industry globally and also covers key themes such as cyber security and diversity. In addition to sector specialisation, Louise is also involved in the team’s corporate engagement and voting activities.
Experience and qualifications
Louise joined Aviva Investors in 2017 having previously worked at Sycomore Asset Management and BNP Paribas Wealth Management.
She holds a Masters’ degree from Sciences Po Paris in Economics & Business.
Senior ESG Analyst
Chief Responsible Investment Officer
Senior Corporate Governance Analyst
Senior GRI Analyst, Climate Specialist
Senior ESG Analyst & Earth Pillar Lead
ESG Operations Manager
Global Head of ESG and Strategic Partnerships
Global Head of ESG Investments
Head of ESG – Sovereign
You might also be interested in
Nature shock: Grappling with nature-based risk
19 Jan 2022
Could nature degradation prove a significant threat to corporate and financial stability? As climate change accelerates, oceans acidify, deforestation and soil erosion continue and species are lost, this important question is weighing on investors and financial regulators around the world.
The AIQ Podcast: Embracing neurodiversity at work
12 Jan 2022
Employers have considerable room for improvement when it comes to the working experience for neurodivergent individuals. But a little more understanding and some fairly simple adjustments could make a world of difference.
Investing for climate action: Easy as SBTs?
11 Jan 2022
With governments struggling to turn words into action on climate change, investors can ensure the private sector plays its part by pushing firms to adopt science-based targets, argues Rick Stathers.
Lessons from tech and military: Why asset managers need to be agile to stay effective and relevant
22 Dec 2021
Asset managers must promote diversity of thought if they are to future-proof their businesses and provide clients with great service. They can learn valuable lessons on how to do this from tech companies, military leaders and ancient philosophers, writes Apiramy Jeyarajah, head of UK wholesale at Aviva Investors.
A tough job: Decarbonising heavy industry
20 Dec 2021
Heavy industry and heavy-duty transport are responsible for nearly a third of global carbon dioxide emissions. While reducing emissions from these sectors will be difficult, the transformation will create opportunities for investors.
The social transition: Investing for a more equitable world
14 Dec 2021
Recognising that being a good corporate citizen is the right thing to do and pays off is something investors and the financial community need to think harder about, argue Vaidehee Sachdev and Matt Kirby.
Where the wild things are: Why investors should care about natural capital
14 Dec 2021
Finance must wake up to the risks associated with biodiversity loss and the opportunities that arise from nature-friendly solutions, argue Eugenie Mathieu, Julie Zhuang and Jonathan Toub.
No more lip-service on diversity and inclusion – three principles for financial institutions to follow
13 Dec 2021
In part two of our series on intersectionality, Apiramy Jeyarajah, head of UK wholesale at Aviva Investors, and Mitesh Sheth, outgoing CEO of Redington, explain what investment organisations can do to maximise the return on their most important assets – their people.
Waste not, want not: An investor’s guide to the circular economy
10 Dec 2021
Using the examples of electronics, food, autos and fashion, we explore the benefits of, and challenges to achieving, a more circular economy.
Restoring and caring for the natural world: An interview with John Willis
9 Dec 2021
Scientists around the world have highlighted the need to tread more lightly on the planet, halting then reversing the decline of the natural world. But the financial community, including investors, has been slow to respond.
The future of pharma: Increased returns or the age of biotech?
8 Dec 2021
After decades of low returns on research and development (R&D), the healthcare sector is producing a slew of innovations, from drugs to diagnostics. But with many coming from new entrants, will big pharmaceutical companies manage to keep up with the times?
The cost of climate change: A big threat to sovereign debt?
3 Dec 2021
Governments around the world are struggling to avert a climate catastrophe. Regardless of whether they succeed, climate change threatens adverse consequences for government bonds, although market impacts are likely to vary.
Thinking outside the box: Embracing neurodiversity at work
30 Nov 2021
Enabling neuroinclusion in the workplace still has a long way to go, although better understanding and simple adjustments could make a world of difference.
What does the data say? Parcels, the (other) Amazon and COVID-19
26 Nov 2021
In this month’s instalment of our visual series on topical data themes, we look at the steep increase in deliveries, the continued deforestation of the Amazon rainforest and the rise of COVID-19 in Europe.
Credit: The long and short of ESG investing
25 Nov 2021
Credit is an asymmetric asset class. The upside is a coupon payment and limited capital appreciation; the downside is a default to zero. For all maturities and bond types, ESG integration can play a crucial role in mitigating risk.
The tyranny of “fit”: If businesses want to maximise their potential, they need to be intersectional
24 Nov 2021
Employees are a company’s greatest asset. Leaders must take an inclusive, intersectional approach to enable them to give their best, argues Apiramy Jeyarajah.